Ginkgo Bioworks Holdings, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 4 insiders sold $3.6M, 0 of 15 sales on a 10b5-1 plan.→HoldersBlackRock 6.7%Viking Global Investors 5.6%Erste Asset Management GmbH 4.0%→Financing →PeersClosest companies: CTKB, BNGO, MXCT→
From the filings
Figures
- Revenue
- $111.9Mlast 12 months
- Net income
- −$290.8Mlast 12 months
- Operating cash flow
- −$166.2Mlast 12 months
- Cash and equivalents
- $84.5Mat the last balance sheet
- Shares outstanding
- 63.7M shareson issue